Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling ParametersKevin H.M. Kuo, Susan P. Perrine, Aidan Faller et al.|Blood|2023Cited by 2
PB-04 Induces HbF Expression in a Ph1b Trial in Sickle Cell DiseaseSusan P. Perrine, Patrick C. Hines, Kevin H.M. Kuo et al.|Journal of sickle cell disease.|2024Cited by 1